期刊
MOLECULES
卷 27, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/molecules27041315
关键词
organoselenium; isoselenoureas; selenocarbamates; isoselenocarbamates; polyphenols; antioxidant; GPx mimetic; antiproliferative agents
资金
- Spanish MICINN [PID2020-116460RB-I00]
- Junta de Andalucia [FQM134]
- Canary Islands Government
- European Regional Development Fund (ACIISI/FEDER, UE) [ProID2020010101]
The study focuses on the preparation of novel hybrids combining organoselenium and polyphenolic compounds to obtain new antioxidants and antiproliferative agents. The compounds showed excellent antioxidant properties and potent antiproliferative activity against lung cancer cell lines. These findings suggest their potential as new drug candidates.
Being aware of the enormous biological potential of organoselenium and polyphenolic compounds, we have accomplished the preparation of novel hybrids, combining both pharmacophores in order to obtain new antioxidant and antiproliferative agents. Three different families have been accessed in a straightforward and chemoselective fashion: carbohydrate-containing N-acylisoselenoureas, N-arylisoselenocarbamates and N-arylselenocarbamates. The nature of the organoselenium framework, number and position of phenolic hydroxyl groups and substituents on the aromatic scaffolds afforded valuable structure-activity relationships for the biological assays accomplished: antioxidant properties (antiradical activity, DNA-protective effects, Glutathione peroxidase (GPx) mimicry) and antiproliferative activity. Regarding the antioxidant activity, selenocarbamates 24-27 behaved as excellent mimetics of GPx in the substoichiometric elimination of H2O2 as a Reactive Oxygen Species (ROS) model. Isoselenocarbamates and particularly their selenocarbamate isomers exhibited potent antiproliferative activity against non-small lung cell lines (A549, SW1573) in the low micromolar range, with similar potency to that shown by the chemotherapeutic agent cisplatin (cis-diaminodichloroplatin, CDDP) and occasionally with more potency than etoposide (VP-16).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据